LianBio Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
LianBio (LIANY) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $3.90 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2023-03-28
- LianBio valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $3.90M.
- LianBio valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was -$33.50M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2022-12-31 | $3.90M 10-K · filed 2023-03-28 |
| 2021-12-31 | -$33.50M 10-K · filed 2022-03-31 |